Literature DB >> 8014489

Neutrophil activation by Helicobacter pylori lipopolysaccharides.

H Nielsen1, S Birkholz, L P Andersen, A P Moran.   

Abstract

Helicobacter pylori-induced release of toxic substances by neutrophils could be of potential importance in the pathogenesis of gastroduodenal inflammatory diseases. Lipopolysaccharide (LPS) has the ability to induce neutrophil activation at very low concentrations. Neutrophil oxidative metabolism and enzyme release were assessed after stimulation of neutrophils with various preparations of LPS from H. pylori and compared with that obtained with Salmonella typhimurium LPS. No direct activation of neutrophils by LPS was observed. Preincubation with LPS showed a significant priming for increased activity on subsequent stimulation, particularly with rough-form LPS. The potency of H. pylori LPS was 10-fold lower than that of S. typhimurium LPS, probably reflecting the unique biochemical structure of H. pylori LPS. Chronic low-grade stimulation by H. pylori LPS in the gastric mucosa may render neutrophils primed for the excessive release of detrimental substances into the tissue on stimulation by other mediators.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8014489     DOI: 10.1093/infdis/170.1.135

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  28 in total

1.  Priming of neutrophil respiratory burst activity by lipopolysaccharide from Burkholderia cepacia.

Authors:  J E Hughes; J Stewart; G R Barclay; J R Govan
Journal:  Infect Immun       Date:  1997-10       Impact factor: 3.441

2.  Surreptitious manipulation of the human host by Helicobacter pylori.

Authors:  Dawn A Israel; Richard M Peek
Journal:  Gut Microbes       Date:  2010-03

3.  Rapid development of severe hyperplastic gastritis with gastric epithelial dedifferentiation in Helicobacter felis-infected IL-10(-/-) mice.

Authors:  D J Berg; N A Lynch; R G Lynch; D M Lauricella
Journal:  Am J Pathol       Date:  1998-05       Impact factor: 4.307

4.  Reactivities of Lewis antigen monoclonal antibodies with the lipopolysaccharides of Helicobacter pylori strains isolated from patients with gastroduodenal diseases in Japan.

Authors:  K Amano; S Hayashi; T Kubota; N Fujii; S Yokota
Journal:  Clin Diagn Lab Immunol       Date:  1997-09

Review 5.  Progress in the synthesis and biological evaluation of lipid A and its derivatives.

Authors:  Jian Gao; Zhongwu Guo
Journal:  Med Res Rev       Date:  2017-06-16       Impact factor: 12.944

6.  Stimulation of gp91 phagocytic oxidase and reactive oxygen species in neutrophils by an avirulent Salmonella enterica serovar infantis strain protects gnotobiotic piglets from lethal challenge with serovar Typhimurium strain F98 without inducing intestinal pathology.

Authors:  Neil Foster; Scott Hulme; Margaret Lovell; Katharine Reed; Paul Barrow
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

7.  Type I Helicobacter pylori lipopolysaccharide stimulates toll-like receptor 4 and activates mitogen oxidase 1 in gastric pit cells.

Authors:  T Kawahara; S Teshima; A Oka; T Sugiyama; K Kishi; K Rokutan
Journal:  Infect Immun       Date:  2001-07       Impact factor: 3.441

8.  Inflammatory activation of neutrophils by Helicobacter pylori; a mechanism insensitive to pertussis toxin.

Authors:  P S Hansen; P H Madsen; S B Petersen; H Nielsen
Journal:  Clin Exp Immunol       Date:  2001-01       Impact factor: 4.330

9.  The tyrosine kinase BceF and the phosphotyrosine phosphatase BceD of Burkholderia contaminans are required for efficient invasion and epithelial disruption of a cystic fibrosis lung epithelial cell line.

Authors:  Ana S Ferreira; Inês N Silva; Fábio Fernandes; Ruth Pilkington; Máire Callaghan; Siobhán McClean; Leonilde M Moreira
Journal:  Infect Immun       Date:  2014-12-08       Impact factor: 3.441

10.  Expression of adhesion molecules on human granulocytes after stimulation with Helicobacter pylori membrane proteins: comparison with membrane proteins from other bacteria.

Authors:  G Enders; W Brooks; N von Jan; N Lehn; E Bayerdörffer; R Hatz
Journal:  Infect Immun       Date:  1995-07       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.